These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1989175)

  • 1. Use of flow cytometric crossmatching in cardiac transplantation.
    Shenton BK; Glenville BE; Mitcheson AE; Coates E; Talbot D; Givan AL; Kirk A; Dark JH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1153-4. PubMed ID: 1989175
    [No Abstract]   [Full Text] [Related]  

  • 2. Histocompatibility and other rejection risk factors in cardiac transplantation.
    Zerbe TR; Kormos R; Arena V; Griffith B; Hardesty R; Duquesnoy R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1155-6. PubMed ID: 1989176
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes.
    Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte crossmatching by flow cytometry.
    Bray RA
    Methods Mol Biol; 2013; 1034():285-96. PubMed ID: 23775742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of cytotoxic antidonor HLA antibodies and mismatched marrow graft rejection.
    Ting A; Pun A; Atkinson K; Dodds A; Biggs J
    Transplant Proc; 1986 Apr; 18(2):264-6. PubMed ID: 3515662
    [No Abstract]   [Full Text] [Related]  

  • 8. Nebulous humors: defining alloantibodies in the 21st century.
    Warner P
    Hum Immunol; 2009 Aug; 70(8):623-6. PubMed ID: 19374934
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow cytometry crossmatching: a method for monitoring antidonor antibodies in heart transplant recipients.
    Hurley JP; Cook DJ; McCarthy PM; Hobbs RE; Koo AP; Ratliff NB; Klingman LL; Mrzena K; Stewart RW
    Transplant Proc; 1995 Feb; 27(1):1301-2. PubMed ID: 7878891
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes and management of rejection.
    Najarian JS; Ascher NL
    Transplant Proc; 1979 Mar; 11(1):11-6. PubMed ID: 377612
    [No Abstract]   [Full Text] [Related]  

  • 11. Which human leukocyte antigen antibodies are really clinically relevant?
    Opelz G; Claas FH
    Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation.
    Blanco-Garcia RM; López-Alvarez MR; Pascual-Figal DA; Polo-Garcia L; Guerra N; Campillo JA; Muro M; Garcia-Alonso AM; Marin-Moreno I; Valdes M; Alvarez-López MR; Minguela A
    Transplant Proc; 2007 Sep; 39(7):2362-4. PubMed ID: 17889190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossmatching on platelets by flow cytometry.
    Wang GX; Terashita GY; Terasaki PI
    Clin Transpl; 1988; ():381-5. PubMed ID: 3154488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric assessment of HLA alloantibodies.
    Bray RA; Gebel HM; Ellis TM
    Curr Protoc Cytom; 2004 Feb; Chapter 6():Unit 6.16. PubMed ID: 18770795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparous women: is routine antibody screening enough in cardiac transplantation?
    Miller LW; Phelan DL; Noedel N; McBride LR; Pennington DG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1135-6. PubMed ID: 1989169
    [No Abstract]   [Full Text] [Related]  

  • 19. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
    Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
    Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
    Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.